Development and characterization of some novel drug delivery systems for effective management of oral candidiasis
Loading...
Date
item.page.authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Recently, invasive fungal infections have been increasing significantly, contributing to high incidences and mortality in immunosuppressed patients. C. albicans is the most prevalent opportunistic fungal pathogen in humans that can cause severe and often fatal bloodstream infections. Current antifungal agents have several limitations, including that only a small number of classes of antifungals are available, some of which have severe toxicity and high cost. Moreover, the emergence of drug resistance is a new limitation to successful patient outcomes. Therefore, the development of either new antifungal agent with novel targets or new delivery options seems to be an essential strategy for the efficient management of C. albicans infections.
newlineVarious antifungal medicines like fluconazole, posaconazole have been used to treat the disease from last few years, however all these drugs cause some serious complications. Among all, miconazole and voriconazole are the safest medicines with high therapeutic index. However, their efficacy is compromised due to the multidrug resistance as well as low bioavailability. Beauvericin, a cyclic hexadepsipeptide with exceptional antifungal action against candida can be combined with voriconazole and miconazole to further increase its potency.
newlineBeauvericin is able to counteract the multidrug resistance of C. albicans and provides inhibitory effect without significant toxicity as mentioned in the literature. Several studies proved that, beauvericin synergistically enhances the antifungal activity of azole derivatives.
newlineNumerous studies proved the anti-fungal activity of both the drugs selected for the study individually; however, no work has been published till now on a combination of beauvericin and voriconazole.
newlineKeeping this in view, the present study was aimed at developing a delivery system for controlling of these two drugs and to access the superiority of developed system over existing therapies.
newline
newline